Five things that fall apart in the first 30 days after discharge.

Most discharge plans end with a referral. Someone still has to book the appointment, and the person still has to show up. In a 10-state Medicaid study of 90,639 residential discharges for opioid use disorder, 62.5% had no follow-up care within 7 days, and 46.9% still had none at day 30. With alcohol, the gap opens even earlier: only 7.3% of the 14.1 million U.S. adults with alcohol use disorder got any treatment at all in 2019.

After weeks without opioids, tolerance drops: in one BMJ study, every overdose death in the first four months came from patients who had completed detox. People who use stimulants face a related risk from a contaminated supply; in 2022, more than half of fatal synthetic opioid overdoses also involved stimulants. With alcohol, everyone tends to treat the first drink as no big deal, including the family, which is exactly why a return to drinking is easy to miss.

A 2024 study that tracked people day by day for 30 days after residential discharge found that on days with an outpatient therapy session, the odds of using were about 68% lower. Meetings work the same way: among young adults, more 12-step attendance, and especially active involvement, was linked to more days abstinent.

Research on adolescents found relapses most often happened under social pressure to use. Where someone lives makes one of the biggest differences: young adults who lived in a recovery residence after treatment were about 6 times more likely to stay continuously abstinent, yet only 20 to 35% did.

The home itself matters too. A bottle at the back of a cabinet, paraphernalia in a drawer or the car, an old prescription in the bathroom: any reminder of past use can set off a craving in the first days home, often before the person even realizes what happened. Families usually don’t know every place to look, and the person coming home shouldn’t have to go hunting for it on day one.

In two randomized trials, people who received scheduled recovery check-ups returned to treatment more often (55% vs 37%) and got back an average of 384 days sooner. Catching a slip in week two is a very different situation from finding out about it in month four.

Younger patients leave treatment soonest, no matter the substance. In residential treatment, patients aged 18 to 20 were about half as likely to complete as those 50 and older, and across 88 studies of young people the pooled completion rate was 59%. The largest age dataset, from opioid treatment, shows the same pattern at six months.

For adults in their middle years, the bigger risk is that work, children and finances crowd the plan out. For older adults, it's isolation in a quieter house.

Studies define relapse differently and follow people for different lengths of time; one 2025 review found reported relapse rates ranging from 0% to 95%. What does hold up across studies is that specific supports, when they actually happen, are linked to better outcomes.

None of these does the job on its own. The plans that hold up combine several of them, and someone is responsible for making sure they actually happen.

• Missed or rescheduled appointments, especially the first one.
• A thinning calendar and more unaccounted time.
• Old contacts and places, or new secrecy about phone and money.
• “I’ve got this” replacing the specific plan they left treatment with.

If you see these, get the person back to the plan and the people on it, quickly. If you ever suspect an overdose, use naloxone and call 911.

Treatment teams can request our 30-day handoff checklist through the referral partner form.